Literature DB >> 10902823

Predictive value of serial middle cerebral and renal artery pulsatility indices in fetuses with oligohydramnios.

L L Scott1, B M Casey, S Roberts, D McIntire, D M Twickler.   

Abstract

OBJECTIVE: To determine if unexplained changes in the amniotic fluid index or pulsatility indices of the fetal renal, middle cerebral, or umbilical artery are predictive of perinatal outcome in pregnancies complicated by oligohydramnios.
METHODS: Changes in amniotic fluid measurements and fetal vessel velocimetry in patients with oligohydramnios were evaluated for correlation with fetal outcome. Fourteen fetuses with oligohydramnios underwent serial sonography evaluating the amniotic fluid index and fetal middle cerebral, renal, and umbilical velocimetry. Matched controls and neonatal outcomes were obtained.
RESULTS: Change in amniotic fluid index and in renal artery pulsatility index were inversely correlated. Change in the middle cerebral artery pulsatility index was different in infants with normal outcome compared to infants with adverse outcome
CONCLUSIONS: Serial velocimetry of the middle cerebral artery may identify fetuses with oligohydramnios at risk for adverse outcomes.

Entities:  

Mesh:

Year:  2000        PMID: 10902823     DOI: 10.1002/(SICI)1520-6661(200003/04)9:2<105::AID-MFM3>3.0.CO;2-V

Source DB:  PubMed          Journal:  J Matern Fetal Med        ISSN: 1057-0802


  2 in total

1.  Renal Artery Doppler Findings in the Patients with Polyhydramnios before and after the Conservative Treatment.

Authors:  Melek Akdogan; Ali İpek; Aydın Kurt; Aslı Tanrıvermis Sayit; Mustafa Karaoglanoglu
Journal:  Eurasian J Med       Date:  2015-06

Review 2.  An unfavorable intrauterine environment may determine renal functional capacity in adulthood: a meta-analysis.

Authors:  Janaína Campos Senra; Mariana Azevedo Carvalho; Agatha Sacramento Rodrigues; Vera Lúcia Jornada Krebs; Maria Augusta Bento Cicaroni Gibelli; Rossana Pulcineli Vieira Francisco; Lisandra Stein Bernardes
Journal:  Clinics (Sao Paulo)       Date:  2018-10-18       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.